Gene therapy using recombinant adenoviral or adeno-associated viral vectors coding for AQP1 (AdhAQP1) were capable to restore saliva flow to irradiated salivary glands of animals and human with Sjögren’s syndrome [102,103,104,105,106,107], as well as to resolve inflammation [108]. This evidence concerns the gene AQP1 and Sjogren syndrome.